Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7

Vaccine

Volumn 28, Issue 30, 2010, Pages 4777-4785

  Mohawk, Krystle L ^a   Melton Celsa, Angela R ^a   Robinson, Cory M ^a   O'Brien, Alison D ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Anti Shiga toxin; E. coli O157:H7 colonization; Shiga toxin

Indexed keywords

MUTANT PROTEIN; NEUTRALIZING ANTIBODY; VEROTOXIN 2; BACTERIUM ANTIBODY; TOXOID;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CAUSE OF DEATH; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; MORBIDITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FECES; FEMALE; GENETICS; IMMUNOLOGY; MICROBIOLOGY; RABBIT; SERODIAGNOSIS; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FECES; FEMALE; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RABBITS; SHIGA TOXIN 2; TOXOIDS; VACCINATION; WEIGHT LOSS;

EID: 77954216766     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.099     Document Type: Article

References (52)

1. Mead P.S., Slutsker L., Dietz V., McCaig L.F., Bresee J.S., Shapiro C., et al. Food-related illness and death in the United States. Emerg Infect Dis 1999, 5(5):607-625.
2. Gould L.H., Demma L., Jones T.F., Hurd S., Vugia D.J., Smith K., et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 2009, 49(10):1480-1485.
3. Manning S.D., Motiwala A.S., Springman A.C., Qi W., Lacher D.W., Ouellette L.M., et al. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci USA 2008, 105(12):4868-4873.
4. CDC. Update on Multi-State Outbreak of E. coli O157:H7 Infections From Fresh Spinach, October 6, 2006. E. coli O157:H7 Outbreak from Fresh Spinach 2006 October 6, 2006 [cited 2009 October 28]; available from: http://www.cdc.gov/foodborne/ecolispinach/100606.htm.
5. CDC. Multistate Outbreak of E. coli O157:H7 Infections Linked to Eating Raw Refrigerated Prepackaged Cookie Dough. 2009 August 7, 2009 [cited 2009]; available from: http://www.cdc.gov/ecoli/2009/0807.html.
6. Karmali M.A., Petric M., Lim C., Fleming P.C., Arbus G.S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985, 151(5):775-782.
7. Obrig T.G. Shiga toxin mode of action in E. coli O157:H7 disease. Front Biosci 1997, 2:d635-d642.
8. Melton-Celsa A.R., Smith M.J., O'Brien A.D. Shiga toxins: potent poisons, pathogenicity determinants, and pharmacological agents. EcoSal-Escherichia coli and Salmonella: cellular and molecular biology 2005, ASM Press, Washington, DC, 29 March, posting date. A. Bock, R. Curtiss, J.B. Kaper, P.D. Karp, F.C. Neidhardt, T. Nystrom (Eds.).
9. Gerner-Smidt P., Hyytia-Trees E., MacCannell D., Leeper M.M., Gould L.H., Lanier W.A. Molecular surveillence of Shiga toxin-producing Escherichia coli-the American experience. 3rd Pathogenic Escherichia coli Network (PEN) conference, entitled epidemiology and transmission of VTEC and other pathogenic Escherichia coli 2008, 78-82.
10. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998, 11(1):142-201.
11. Robinson C.M., Sinclair J.F., Smith M.J., O'Brien A.D. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci USA 2006, 103(25):9667-9672.
12. Sinclair J.F., O'Brien A.D. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. J Biol Chem 2002, 277(4):2876-2885.
13. Sinclair J.F., Dean-Nystrom E.A., O'Brien A.D. The established intimin receptor Tir and the putative eucaryotic intimin receptors nucleolin and beta1 integrin localize at or near the site of enterohemorrhagic Escherichia coli O157:H7 adherence to enterocytes in vivo. Infect Immun 2006, 74(2):1255-1265.
14. Donnenberg M.S., Tzipori S., McKee M.L., O'Brien A.D., Alroy J., Kaper J.B. The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest 1993, 92(3):1418-1424.
15. McKee M.L., Melton-Celsa A.R., Moxley R.A., Francis D.H., O'Brien A.D. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun 1995, 63(9):3739-3744.
16. Sinclair J.F., O'Brien A.D. Intimin types alpha, beta, and gamma bind to nucleolin with equivalent affinity but lower avidity than to the translocated intimin receptor. J Biol Chem 2004, 279(32):33751-33758.
17. Ostroff S.M., Griffin P.M., Tauxe R.V., Shipman L.D., Greene K.D., Wells J.G., et al. A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol 1990, 132(2):239-247.
18. Gunzer F., Bohn U., Fuchs S., Muhldorfer I., Hacker J., Tzipori S., et al. Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli. Infect Immun 1998, 66(5):2337-2341.
19. Kokai-Kun J.F., Melton-Celsa A.R., O'Brien A.D. Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J Biol Chem 2000, 275(5):3713-3721.
20. Mohawk K.L., Melton-Celsa A.R., Zangari T., Carroll E.E., O'Brien A.D. Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb Pathog 2010, 48(3-4):131-142.
21. NIH guidelines for research involving recombinant DNA molecules 2009, September. Services DoHaH (Ed.).
22. Sjogren R., Neill R., Rachmilewitz D., Fritz D., Newland J., Sharpnack D., et al. Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. Gastroenterology 1994, 106(2):306-317.
23. Hoffman M.A., Menge C., Casey T.A., Laegreid W., Bosworth B.T., Dean-Nystrom E.A. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7. Clin Vaccine Immunol 2006, 13(12):1322-1327.
24. Calderon Toledo C., Rogers T.J., Svensson M., Tati R., Fischer H., Svanborg C., et al. Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Am J Pathol 2008, 173(5):1428-1439.
25. Dean-Nystrom E.A., Stoffregen W.C., Bosworth B.T., Moon H.W., Pohlenz J.F. Early attachment sites for Shiga-toxigenic Escherichia coli O157:H7 in experimentally inoculated weaned calves. Appl Environ Microbiol 2008 Oct, 74(20):6378-6384.
26. Baines D., Erb S., McAllister T. Stx2 from enterohemorrhagic Escherichia coli O157:H7 promotes colonization in the intestine of cattle. Can J Anim Sci 2008, 88:581-584.
27. Yin X., Chambers J.R., Wheatcroft R., Johnson R.P., Zhu J., Liu B., et al. Adherence of Escherichia coli O157:H7 mutants in vitro and in ligated pig intestines. Appl Environ Microbiol 2009, 75(15):4975-4983.
28. Lowe R.M., Baines D., Selinger L.B., Thomas J.E., McAllister T.A., Sharma R. Escherichia coli O157:H7 strain origin, lineage, and Shiga toxin 2 expression affect colonization of cattle. Appl Environ Microbiol 2009, 75(15):5074-5081.
29. Ritchie J.M., Thorpe C.M., Rogers A.B., Waldor M.K. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 2003, 71(12):7129-7139.
30. Best A., La Ragione R.M., Cooley W.A., O'Connor C.D., Velge P., Woodward M.J. Interaction with avian cells and colonisation of specific pathogen free chicks by Shiga-toxin negative Escherichia coli O157:H7 (NCTC 12900). Vet Microbiol 2003, 93(3):207-222.
31. Sheng H., Lim J.Y., Knecht H.J., Li J., Hovde C.J. Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa. Infect Immun 2006, 74(8):4685-4693.
32. Cornick N.A., Helgerson A.F., Sharma V. Shiga toxin and Shiga toxin-encoding phage do not facilitate Escherichia coli O157:H7 colonization in sheep. Appl Environ Microbiol 2007, 73(1):344-346.
33. Eaton K.A., Friedman D.I., Francis G.J., Tyler J.S., Young V.B., Haeger J., et al. Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect Immun 2008, 76(7):3054-3063.
34. Berberov E.M., Zhou Y., Francis D.H., Scott M.A., Kachman S.D., Moxley R.A. Relative importance of heat-labile enterotoxin in the causation of severe diarrheal disease in the gnotobiotic piglet model by a strain of enterotoxigenic Escherichia coli that produces multiple enterotoxins. Infect Immun 2004, 72(7):3914-3924.
35. Allen K.P., Randolph M.M., Fleckenstein J.M. Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains. Infect Immun 2006, 74(2):869-875.
36. Olivier V., Salzman N.H., Satchell K.J. Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins. Infect Immun 2007, 75(10):5043-5051.
37. Salama N.R., Otto G., Tompkins L., Falkow S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun 2001, 69(2):730-736.
38. Cover T.L., Blanke S.R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005, 3(4):320-332.
39. Schwan C., Stecher B., Tzivelekidis T., van Ham M., Rohde M., Hardt W.D., et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog 2009, 5(10):e1000626.
40. Keller M.A., Stiehm E.R. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000, 13(4):602-614.
41. Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis 2002, 8(8):833-841.
42. Wadolkowski E.A., Sung L.M., Burris J.A., Samuel J.E., O'Brien A.D. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 1990, 58(12):3959-3965.
43. Karpman D., Connell H., Svensson M., Scheutz F., Alm P., Svanborg C. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 1997, 175(3):611-620.
44. Donohue-Rolfe A., Kondova I., Mukherjee J., Chios K., Hutto D., Tzipori S. Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2. Infect Immun 1999, 67(7):3645-3648.
45. Matise I., Cornick N.A., Booher S.L., Samuel J.E., Bosworth B.T., Moon H.W. Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli. J Infect Dis 2001, 183(2):347-350.
46. Sheoran A.S., Chapman-Bonofiglio S., Harvey B.R., Mukherjee J., Georgiou G., Donohue-Rolfe A., et al. Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun 2005, 73(8):4607-4613.
47. Yamagami S., Motoki M., Kimura T., Izumi H., Takeda T., Katsuura Y., et al. Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli. J Infect Dis 2001, 184(6):738-742.
48. Gordon V.M., Whipp S.C., Moon H.W., O'Brien A.D., Samuel J.E. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun 1992, 60(2):485-490.
49. Bosworth B.T., Samuel J.E., Moon H.W., O'Brien A.D., Gordon V.M., Whipp S.C. Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun 1996, 64(1):55-60.
50. MacLeod D.L., Gyles C.L. Immunization of pigs with a purified Shiga-like toxin II variant toxoid. Vet Microbiol 1991, 29(3-4):309-318.
51. Wen S.X., Teel L.D., Judge N.A., O'Brien A.D. A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2. Proc Natl Acad Sci USA 2006, 103(18):7082-7087.
52. Zhu C., Yu J., Yang Z., Davis K., Rios H., Wang B., et al. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B. Clin Vaccine Immunol 2008, 15(2):359-366.